TrialBritish journal of cancer2004

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC).

F Cappuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.